MicroRNA-133b suppresses bladder cancer malignancy by targeting TAGLN2-mediated cell cycle

MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer

(2018) Shushan Yan et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

TAGLN2 is a candidate prognostic biomarker promoting tumorigenesis in human gliomas

(2017) Ming-Zhi Han et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiR-361-5p inhibits glycolytic metabolism, proliferation and invasion of breast cancer by targeting FGFR1 and MMP-1

(2017) Fei Ma et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Identification of hub miRNA biomarkers for bladder cancer by weighted gene coexpression network analysis

(2017) Feng Zhao et al.   OncoTargets and Therapy

MiR-133b inhibits growth of human gastric cancer cells by silencing pyruvate kinase muscle-splicer polypyrimidine tract-binding protein 1

(2016) Taro Sugiyama et al.   CANCER SCIENCE

MicroRNA-133b inhibits hepatocellular carcinoma cell progression by targeting Sirt1

(2016) Zhijie Tian et al.   EXPERIMENTAL CELL RESEARCH

Actin, actin-binding proteins, and actin-related proteins in the nucleus

(2016) Ildikó Kristó et al.   HISTOCHEMISTRY AND CELL BIOLOGY

Functional significance of transgelin-2 in uterine cervical squamous cell carcinoma

(2016) Kazuyuki Yakabe et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Identification and verification of transgelin-2 as a potential biomarker of tumor-derived lung-cancer endothelial cells by comparative proteomics

(2016) Hongwei Jin et al.   Journal of Proteomics

miR-133b inhibits glioma cell proliferation and invasion by targeting Sirt1

(2016) Chuntao Li et al.   Oncotarget

Salvianolic acid A reverses the paclitaxel resistance and inhibits the migration and invasion abilities of human breast cancer cells by inactivating transgelin 2

(2015) Xiaowei Zheng et al.   CANCER BIOLOGY & THERAPY

Glucose promotes cell proliferation, glucose uptake and invasion in endometrial cancer cells via AMPK/mTOR/S6 and MAPK signaling

(2015) Jianjun Han et al.   GYNECOLOGIC ONCOLOGY

Targeting Cyclin-Dependent Kinases and Cell Cycle Progression in Human Cancers

(2015) Loredana Santo et al.   SEMINARS IN ONCOLOGY

The novel protective role of P27 in MLN4924-treated gastric cancer cells

(2015) Q Zhang et al.   Cell Death & Disease

miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma

(2015) Nijiro Nohata et al.   Oncotarget

TAp63 suppress metastasis via miR-133b in colon cancer cells

(2014) C W Lin et al.   BRITISH JOURNAL OF CANCER

Transgelins, cytoskeletal proteins implicated in different aspects of cancer development

(2014) Monika Dvorakova et al.   Expert Review of Proteomics

MiR-145, miR-133a and miR-133b inhibit proliferation, migration, invasion and cell cycle progression via targeting transcription factor Sp1 in gastric cancer

(2014) Tianzhu Qiu et al.   FEBS LETTERS

Combined downregulation of microRNA-133a and microRNA-133b predicts chemosensitivity of patients with esophageal squamous cell carcinoma undergoing paclitaxel-based chemotherapy

(2014) Guiming Chen et al.   MEDICAL ONCOLOGY

Planning your every move: The role of β-actin and its post-transcriptional regulation in cell motility

(2014) Lise Artman et al.   SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY

Molecular Mechanisms of RNA Interference

(2013) Ross C. Wilson et al.   Annual Review of Biophysics

Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells

(2013) Ha-Na Choi et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MicroRNA-195-5p suppresses glucose uptake and proliferation of human bladder cancer T24 cells by regulatingGLUT3expression

(2012) Xiang Fei et al.   FEBS LETTERS

New Therapeutic Challenges in Advanced Bladder Cancer

(2012) Joaquim Bellmunt et al.   SEMINARS IN ONCOLOGY

Bladder cancer

(2010) Daniel A Barocas et al.   CURRENT OPINION IN ONCOLOGY

Late Recurrence and Progression in Non-muscle–invasive Bladder Cancers After 5-year Tumor-free Periods

(2010) Kazuhiro Matsumoto et al.   UROLOGY

Identification of transgelin-2 as a biomarker of colorectal cancer by laser capture microdissection and quantitative proteome analysis

(2009) Yanbin Zhang et al.   CANCER SCIENCE

Recurrence and Progression of Disease in Non–Muscle-Invasive Bladder Cancer: From Epidemiology to Treatment Strategy

(2009) Bas W.G. van Rhijn et al.   EUROPEAN UROLOGY

Tissue Proteomics Reveals Differential and Compartment-Specific Expression of the Homologs Transgelin and Transgelin-2 in Lung Adenocarcinoma and Its Stroma

(2009) Jung-hyun Rho et al.   JOURNAL OF PROTEOME RESEARCH

Cancer Cell Metabolism: Warburg and Beyond

(2008) Peggy P. Hsu et al.   CELL

CDK Inhibitors: Cell Cycle Regulators and Beyond

(2008) Arnaud Besson et al.   DEVELOPMENTAL CELL

p27Kip1 Inhibits Cyclin D-Cyclin-Dependent Kinase 4 by Two Independent Modes

(2008) A. Ray et al.   MOLECULAR AND CELLULAR BIOLOGY